Testy Oversight and Government Reform Committee Hearing on Prescription…
The United States House Oversight and Government Reform Committee held a hearing on developments in the prescription…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Physician Payment Sunshine Act: Open Payments Final 2015 Data Submission…
In our latest endeavor to try to help you wade through the lengthy regulations known as Open Payments leading up to the…
Open Payments Question & Answer Session on February 9, 2016
Centers for Medicare and Medicaid Services is hosting an informal Question and Answer session on February 9, 2016, from…
ICMEJ Proposes Data Socialism – Data Utopianism Has its Cracks –…
The International Committee of Medical Journal Editors (ICMJE) recently put forth a proposed set of new requirements for…
European Medicines Agency: Framework for Interaction with Industry
The European Medicines Agency's (EMA) Management Board has adopted a new framework to govern interaction between the…
DOJ Becoming Comfortable With Permitting Truthful, Non-misleading Promotion
As we know all too well, the U.S. Food and Drug Administration (FDA) has long taken the position that a medical device…
ProPublica HIPAA Helper or HIPAA Wall of Shame
ProPublica, the same organization who brought us "Dollars for Docs" and the "Surgeon Scorecard," is once again making a…
Another Transparency Threat – Health Education Exchanges and Medical…
We have previously drawn attention to some of the downsides of transparency as it relates to medical information. Those…
FDA CDER Update 2016
We recently reported that 2015 resulted in the highest level of newly approved U.S. drugs in nineteen years. This…
Senators Wyden and Grassley Request Public Comments on Gilead Pricing
On the heels of their December 1, 2015, report on Gilead Sciences' pricing of Hepatitis C drugs Sovaldi and Harvoni,…